¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2024 ´ç´¢º´½ÅÁõ ½ÉÆ÷Áö¾ö : 2024-07-13

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2024 ´ç´¢º´½ÅÁõ ½ÉÆ÷Áö¾ö : 2024-07-13
±³À°ÀÏÀÚ : 2024-07-13
±³À°Àå¼Ò : ¹é¹ü±è±¸±â³ä°ü

±³À°ÁÖÁ¦ : 2024 ´ç´¢º´½ÅÁõ ½ÉÆ÷Áö¾ö

ÁÖÃÖ±â°ü : ´ëÇÑ´ç´¢º´ÇÐȸ
´ã´çÀÚ : À¯ÁöÀÎ
¿¬¶ôó : 02-714-9072  

À̸ÞÀÏ : diabetes@kams.or.kr

±³À°Á¾·ù : ³»°ú

Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 3Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 45ºÐ

¼¼ºÎ¼ö°­·á : 10,000¿ø  

ºñ°í »çÀüµî·Ï 1¸¸¿ø, ÇöÀåµî·Ï 2¸¸¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 07¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 13:05~13:25 eGFR trajectory ±è»ó¼ö (ºÎ»êÀÇ´ë)

±³À°½Ã°£ 07¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 13:25~13:45 Novel risk prediction equation for cardio- kidney-metabolic health Á¤ÀÎÇÏ(°í·ÁÀÇ´ë)

±³À°½Ã°£ 07¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 13:45~14:05 New biomarkers for prediction of DKD ±è¹Ì°æ(°è¸íÀÇ´ë)

Åä·Ð 07¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 14:05~14:20 ÆгÎÅäÀÇ ±èÈ¿Á¤(À»ÁöÀÇ´ë)

±³À°½Ã°£ 07¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 14:20~14:40 DKD and MASLD crosstalk in T2D ¹èÀçÇö(ÇѸ²ÀÇ´ë)

±³À°½Ã°£ 07¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 14:40~15:00 Cardiorenal Nexus in Diabetes À̽ÂÀº(µ¿±¹ÀÇ´ë)

±³À°½Ã°£ 07¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 15:00~15:20 Gut microbiome- DKD ¼­´ÙÇý(ÀÎÇÏÀÇ´ë)

Åä·Ð 07¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 15:20~15:35 ÆгÎÅäÀÇ ±è¼ö°æ(°æ»óÀÇ´ë)

ÈÞ½Ä 07¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 15:35~16:00 Coffee Break ()

±³À°½Ã°£ 07¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 16:00~16:20 Nutritional interventions of diabetic kidney disease Â÷ÁøÁÖ(°í·ÁÀÇ´ë)

±³À°½Ã°£ 07¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 16:20~16:40 Update clinical trials of SGLT2i, GLPT-1 RA °í°üÇ¥(Á¦ÁÖÀÇ´ë )

±³À°½Ã°£ 07¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 16:40~17:00 Finerenone for the management of diabetic kidney disease ±èµ¿¸²(°Ç±¹ÀÇ´ë)

Åä·Ð 07¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 17:00~17:15 ÆгÎÅäÀÇ ±è³²ÈÆ(°í·ÁÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2024 ´ç´¢º´½ÅÁõ ½ÉÆ÷Áö¾ö : 2024-07-13""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Çѱ¹¹é³»Àå±¼Àý¼ö¼úÇÐȸ 2024 KSCRS Annual Symposium(1ÀÏÂ÷) : 2024-07-13
´ÙÀ½±Û ´ëÇÑÇ÷°üÇÐȸ KOVAS 2024 Summer Conference (1ÀÏÂ÷) : 2024-07-12
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
71 ¼­¿ï Á¦3ȸ ´ëÇѼҾÆû¼Ò³â°úÀÇ»çȸ ÃÊÀ½ÆÄ¿öÅ©¼¥ : 2018-08-19 0 607 2018-07-28
70 ¼­¿ï ´ëÇѺñ°úÇÐȸ RHINOLOGY UPDATE SYMPOSIUM IN 2018 : 2018-08-18 0 464 2018-07-28
69 ´ë±¸ 2018³âµµ ´ëÇѽŰæ¿Ü°úÇÐȸ ´ë±¸¡¤°æºÏÁöȸ Á¦3Â÷ ¿¬¼ö±³À° : 2018-08-18 0 456 2018-07-28
68 °æ±â 2018 °í·Á´ëÇб³¾È»êº´¿ø °¡Á¤ÀÇÇаú °³¿øÀÇ ¿¬¼ö°­Á : 2018-08-18 0 694 2018-07-28
67 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø Highlighted Access on Disease Recurrence Of Cervical cancer(HADROC) Symposium : 2018-08-18 0 604 2018-07-28
66 ¼­¿ï 2018 ´ëÇѽÉÆóÇ÷°ü¸¶ÃëÇÐȸ ¿¬¼ö°­Á : 2018-08-18 0 576 2018-07-28
65 ¼­¿ï 2018 ´ëÇѽÉÆóÇ÷°ü¸¶ÃëÇÐȸ TEE Workshop : 2018-08-18 0 723 2018-07-28
64 ºÎ»ê ´ëÇѽɺÎÀüÇÐȸ ÇÏ°è ½ÉÆ÷Áö¾ö : 2018-08-18 0 578 2018-07-28
63 °æ±â ÇѸ²´ëÇб³¼º½Éº´¿ø Á¦7ȸ Áö¿ª»çȸº´¿ø°ú ÇÔ²²ÇÏ´Â °¨¿°°ü¸® ½ÉÆ÷Áö¿ò : 2018-08-18 0 888 2018-07-28
62 ¼­¿ï 2018 ÇÏ°è ºÐÀÚÆó¾Ï¿¬±¸È¸ Àӻ󿬱¸ ¿öÅ©¼ó : 2018-08-18 0 543 2018-07-28
61 ¼­¿ï ´ëÇÑ¿Ü°úÃÊÀ½ÆÄÇÐȸ ÃÊÀ½ÆÄ °Ë»ç ±Ç°í¾È ½ÉÆ÷Áö¾ö : 2018-08-18 0 776 2018-07-28
60 ºÎ»ê 2018³â ´ëÇѼÒÈ­±â¿¬°üÇÐȸ ºÎ¿ï°æÁöȸ ¿¬¼ö°­Á : 2018-08-18 0 675 2018-07-28
59 ¼­¿ï ´ëÇÑ»êºÎÀΰúÀÇ»çȸ&Çѱ¹¹ß»ý»ý¹°ÇÐȸ Joint Symposium : 2018-08-18 0 1,081 2018-07-28
58 ¼­¿ï ´ëÇѺ´¸®ÇÐȸ 8th Ç÷¾×º´¸® ¿¬¼ö±³À° : 2018-08-18 0 715 2018-07-28
57 ¼­¿ï ´ëÇѴٹ߼º°æÈ­ÁõÇÐȸ 2018³â ¿¬·ÊÇмú´ëȸ : 2018-08-18 0 842 2018-07-28
1401 | 1402 | 1403 | 1404 | 1405 | 1406 | 1407 | 1408 | 1409 | 1410
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷